We are pleased to announce that H&Q Healthcare Investors (NYSE: HQH) and H&Q Life Sciences Investors (NYSE: HQL) have changed their names to Tekla Healthcare Investors and Tekla Life Sciences Investors, respectively. The Funds will continue to trade on the NYSE under their current tickers, HQH and HQL. The Funds name changes are designed to reflect continuity amongst the three Funds managed by Tekla Capital Management LLC.

Tekla Capital Management LLC is a Boston, MA based healthcare-focused investment manager with approximately $2.3 billion of assets under management as of September 30, 2014. Tekla serves as investment adviser to three closed-end funds: Tekla Healthcare Investors, Tekla Life Sciences Investors and Tekla Healthcare Opportunities Fund.

Tekla Healthcare Investors is a diversified closed-end healthcare fund that primarily invests in the healthcare industry (including biotechnology, medical devices, and pharmaceuticals). The Fund's objective is to provide long-term capital appreciation through investments in companies in the healthcare industry believed to have significant potential for above-average long-term growth. Selection will emphasize the smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies.

Tekla Life Sciences Investors is a diversified closed-end healthcare fund that invests in the life sciences (including biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies), agriculture and environmental management industries. The Fund's objective is to provide long-term capital appreciation through investments in companies in the life sciences industry believed to have significant potential for above-average long-term growth. Selection will emphasize the smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies.

Tekla Healthcare Opportunities Fund (THQ) is a non-diversified closed-end fund that invests primarily in the healthcare industry. The Fund's objective is to seek current income and long-term capital appreciation through investment companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles.

For additional information, please contact www.teklacap.com or call (617) 772-8500.